• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染患者出现神经系统症状时脑脊液自身抗体的高频出现。

High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.

机构信息

Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Germany.

出版信息

Brain Behav Immun. 2021 Mar;93:415-419. doi: 10.1016/j.bbi.2020.12.022. Epub 2020 Dec 24.

DOI:10.1016/j.bbi.2020.12.022
PMID:33359380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834471/
Abstract

BACKGROUND

COVID-19 intensive care patients can present with neurological syndromes, usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of some virus-neutralizing antibodies cross-reacting with brain tissue suggests the possible involvement of specific autoimmunity.

DESIGN

Blood and CSF samples from eleven critically ill COVID-19 patients presenting with unexplained neurological symptoms including myoclonus, oculomotor disturbance, delirium, dystonia and epileptic seizures, were analyzed for anti-neuronal and anti-glial autoantibodies.

RESULTS

Using cell-based assays and indirect immunofluorescence on unfixed murine brain sections, all patients showed anti-neuronal autoantibodies in serum or CSF. Antigens included intracellular and neuronal surface proteins, such as Yo or NMDA receptor, but also various specific undetermined epitopes, reminiscent of the brain tissue binding observed with certain human monoclonal SARS-CoV-2 antibodies. These included vessel endothelium, astrocytic proteins and neuropil of basal ganglia, hippocampus or olfactory bulb.

CONCLUSION

The high frequency of autoantibodies targeting the brain in the absence of other explanations suggests a causal relationship to clinical symptoms, in particular to hyperexcitability (myoclonus, seizures). Several underlying autoantigens and their potential molecular mimicry with SARS-CoV-2 still await identification. However, autoantibodies may already now explain some aspects of multi-organ disease in COVID-19 and can guide immunotherapy in selected cases.

摘要

背景

COVID-19 重症监护患者可能出现神经系统综合征,通常情况下 COVID-19 病毒不会出现在脑脊液(CSF)中。最近发现一些中和抗体与脑组织发生交叉反应,这表明可能存在特定的自身免疫反应。

设计

从 11 名患有 COVID-19 并出现不明原因神经系统症状(包括肌阵挛、眼球运动障碍、意识障碍、肌张力障碍和癫痫发作)的危重症患者中采集血液和 CSF 样本,分析其是否存在抗神经元和神经胶质自身抗体。

结果

使用基于细胞的检测方法和未经固定的鼠脑切片间接免疫荧光,所有患者的血清或 CSF 中均存在抗神经元自身抗体。抗原包括细胞内和神经元表面蛋白,如 Yo 或 NMDA 受体,还包括各种特定的未知表位,类似于某些人类单克隆 SARS-CoV-2 抗体与脑组织结合的情况。这些抗原包括血管内皮细胞、星形胶质细胞蛋白以及基底节、海马或嗅球的神经原纤维。

结论

在没有其他解释的情况下,大脑中存在大量针对自身的抗体,这表明其与临床症状存在因果关系,尤其是与过度兴奋(肌阵挛、癫痫发作)有关。一些潜在的自身抗原及其与 SARS-CoV-2 的潜在分子模拟仍有待确定。然而,自身抗体可能已经可以解释 COVID-19 中多器官疾病的某些方面,并可以在某些情况下指导免疫治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a13/7834471/4303fad283e8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a13/7834471/4303fad283e8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a13/7834471/4303fad283e8/gr1_lrg.jpg

相似文献

1
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.新冠病毒感染患者出现神经系统症状时脑脊液自身抗体的高频出现。
Brain Behav Immun. 2021 Mar;93:415-419. doi: 10.1016/j.bbi.2020.12.022. Epub 2020 Dec 24.
2
Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.脑脊液脑结合自身抗体与新冠后综合征认知障碍的关联。
Brain Behav Immun. 2023 Mar;109:139-143. doi: 10.1016/j.bbi.2023.01.006. Epub 2023 Jan 16.
3
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.COVID-19 患者的脑脊液检查结果:127 例患者 150 次腰椎穿刺的多中心研究。
J Neuroinflammation. 2022 Jan 20;19(1):19. doi: 10.1186/s12974-021-02339-0.
4
Myoclonus status revealing COVID 19 infection.肌阵挛状态揭示 COVID-19 感染。
Seizure. 2023 Jan;104:12-14. doi: 10.1016/j.seizure.2022.11.010. Epub 2022 Nov 22.
5
SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.新型冠状病毒肺炎患者脑脊液中的严重急性呼吸综合征冠状病毒2和自身抗体:前瞻性多中心队列研究
Brain Commun. 2023 Oct 17;5(5):fcad274. doi: 10.1093/braincomms/fcad274. eCollection 2023.
6
Presence of anti-neuronal antibodies in children with neurological disorders beyond encephalitis.神经疾病患儿中存在抗神经元抗体,这些患儿的疾病不只是脑炎。
Eur J Paediatr Neurol. 2020 Sep;28:159-166. doi: 10.1016/j.ejpn.2020.07.004. Epub 2020 Jul 30.
7
Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.3 例 COVID-19 伴亚急性神经精神症状青少年患者脑脊液中抗 SARS-CoV-2 和自身抗体特征。
JAMA Neurol. 2021 Dec 1;78(12):1503-1509. doi: 10.1001/jamaneurol.2021.3821.
8
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.感染 SARS-CoV-2 患者的免疫介导性神经系统综合征。
J Neurol. 2021 Mar;268(3):751-757. doi: 10.1007/s00415-020-10108-x. Epub 2020 Jul 30.
9
KCNA2 IgG autoimmunity in neuropsychiatric diseases.神经精神疾病中的KCNA2 IgG自身免疫
Brain Behav Immun. 2024 Mar;117:399-411. doi: 10.1016/j.bbi.2024.01.220. Epub 2024 Feb 2.
10
Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.COVID-19 患者出现神经系统症状的脑脊液的下一代测序和蛋白质组学分析。
Front Immunol. 2021 Dec 9;12:782731. doi: 10.3389/fimmu.2021.782731. eCollection 2021.

引用本文的文献

1
Social anxiety disorder and antibodies against glial cells in the cerebrospinal fluid.社交焦虑障碍与脑脊液中抗神经胶质细胞抗体
Brain Behav Immun Health. 2025 Jul 19;48:101064. doi: 10.1016/j.bbih.2025.101064. eCollection 2025 Oct.
2
Novel cerebrospinal fluid anti-central nervous system IgG antibodies can identify immunotherapy-responsive neuropsychiatric disorders.新型脑脊液抗中枢神经系统IgG抗体可识别免疫治疗反应性神经精神障碍。
Front Immunol. 2025 Jul 7;16:1612844. doi: 10.3389/fimmu.2025.1612844. eCollection 2025.
3
Long COVID is associated with female sex; Anti-NCAM1 autoantibodies are absent in patients with long COVID.

本文引用的文献

1
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.一种治疗性非自身反应性 SARS-CoV-2 抗体可预防 COVID-19 仓鼠模型中的肺部病理。
Cell. 2020 Nov 12;183(4):1058-1069.e19. doi: 10.1016/j.cell.2020.09.049. Epub 2020 Sep 23.
2
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.德国 COVID-19 患者的神经病理学:一项尸检病例系列研究。
Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.
3
Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients.
长期新冠与女性性别有关;长期新冠患者不存在抗NCAM1自身抗体。
IBRO Neurosci Rep. 2025 Jul 9;19:252-256. doi: 10.1016/j.ibneur.2025.07.002. eCollection 2025 Dec.
4
Neuroimmune pathophysiology of long COVID.长新冠的神经免疫病理生理学
Psychiatry Clin Neurosci. 2025 Jun 19. doi: 10.1111/pcn.13855.
5
Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts.新型严重急性呼吸综合征冠状病毒2型感染的严重程度与新发自身免疫性疾病的风险:美国全国队列中的一项RECOVER倡议研究。
PLoS One. 2025 Jun 4;20(6):e0324513. doi: 10.1371/journal.pone.0324513. eCollection 2025.
6
Correlation between severe acute respiratory syndrome coronavirus 2 infection and serum anti-neutrophil cytoplasmic antibody formation.严重急性呼吸综合征冠状病毒2感染与血清抗中性粒细胞胞浆抗体形成之间的相关性。
Front Immunol. 2025 May 16;16:1593577. doi: 10.3389/fimmu.2025.1593577. eCollection 2025.
7
SARS-CoV2 infection triggers inflammatory conditions and astrogliosis-related gene expression in long-term human cortical organoids.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染会引发长期人类皮质类器官中的炎症反应和与星形胶质细胞增生相关的基因表达。
Stem Cells. 2025 May 27;43(6). doi: 10.1093/stmcls/sxaf010.
8
Animal models of post-acute COVID-19 syndrome: a call for longitudinal animal studies.急性 COVID-19 综合征后动物模型:呼吁开展纵向动物研究。
Front Immunol. 2025 Feb 26;16:1521029. doi: 10.3389/fimmu.2025.1521029. eCollection 2025.
9
Modulator of VRAC Current 1 Is a Potential Target Antigen in Multiple Sclerosis.VRAC电流调节因子1是多发性硬化症中的潜在靶抗原。
Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200374. doi: 10.1212/NXI.0000000000200374. Epub 2025 Feb 11.
10
Clinical and radiological characteristics and 1-year self-reported outcomes from patients with encephalitis and coronavirus disease 2019.2019年冠状病毒病相关脑炎患者的临床和影像学特征及1年自我报告结局
J Med Case Rep. 2025 Jan 20;19(1):26. doi: 10.1186/s13256-024-05006-z.
新冠病毒感染患者中频繁出现的神经系统表现和与脑病相关的发病率。
Ann Clin Transl Neurol. 2020 Nov;7(11):2221-2230. doi: 10.1002/acn3.51210. Epub 2020 Oct 5.
4
CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.COVID-19 伴有神经系统症状患者的脑脊液生物标志物:病例系列研究。
Neurology. 2021 Jan 12;96(2):e294-e300. doi: 10.1212/WNL.0000000000010977. Epub 2020 Oct 1.
5
Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms.患有神经系统症状的COVID-19患者的脑脊液检查结果
J Neurol Sci. 2020 Nov 15;418:117090. doi: 10.1016/j.jns.2020.117090. Epub 2020 Aug 11.
6
COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network.采用类固醇和多价免疫球蛋白成功治疗与新型冠状病毒肺炎相关的急性坏死性脑病,伴有靶向脑纤维网络的异常IgG。
J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):1004-1006. doi: 10.1136/jnnp-2020-323678. Epub 2020 Jul 10.
7
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.新型冠状病毒肺炎神经系统表现的研究进展:临床、影像学和实验室表现。
Brain. 2020 Oct 1;143(10):3104-3120. doi: 10.1093/brain/awaa240.
8
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.COVID-19 感染对神经系统疾病发展的即时和长期影响。
Alzheimers Res Ther. 2020 Jun 4;12(1):69. doi: 10.1186/s13195-020-00640-3.
9
Neurologic Features in Severe SARS-CoV-2 Infection.严重SARS-CoV-2感染的神经系统特征
N Engl J Med. 2020 Jun 4;382(23):2268-2270. doi: 10.1056/NEJMc2008597. Epub 2020 Apr 15.
10
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.单纯疱疹脑炎后自身免疫性脑炎的频率、症状、危险因素和结局:一项前瞻性观察研究和回顾性分析。
Lancet Neurol. 2018 Sep;17(9):760-772. doi: 10.1016/S1474-4422(18)30244-8. Epub 2018 Jul 23.